Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Ischemic colitis associated with use of a bitter orange-containing dietary weight-loss supplement.

Sultan S, Spector J, Mitchell RM.

Mayo Clin Proc. 2006 Dec;81(12):1630-1.

PMID:
17165643
2.

Possible association of acute lateral-wall myocardial infarction and bitter orange supplement.

Nykamp DL, Fackih MN, Compton AL.

Ann Pharmacother. 2004 May;38(5):812-6. Epub 2004 Mar 16.

PMID:
15026566
3.
4.

Ischemic stroke associated with use of an ephedra-free dietary supplement containing synephrine.

Bouchard NC, Howland MA, Greller HA, Hoffman RS, Nelson LS.

Mayo Clin Proc. 2005 Apr;80(4):541-5.

PMID:
15819293
5.

Variant angina associated with bitter orange in a dietary supplement.

Gange CA, Madias C, Felix-Getzik EM, Weintraub AR, Estes NA 3rd.

Mayo Clin Proc. 2006 Apr;81(4):545-8.

PMID:
16610576
6.

The safety of Citrus aurantium (bitter orange) and its primary protoalkaloid p-synephrine.

Stohs SJ, Preuss HG, Shara M.

Phytother Res. 2011 Oct;25(10):1421-8. doi: 10.1002/ptr.3490. Epub 2011 Apr 8. Review.

PMID:
21480414
7.

Response of CEDIA amphetamines assay after a single dose of bitter orange.

Nguyen DT, Bui LT, Ambrose PJ.

Ther Drug Monit. 2006 Apr;28(2):252-4.

PMID:
16628139
8.

"Ephedra-free" diet pill-induced psychosis.

Retamero C, Rivera T, Murphy K.

Psychosomatics. 2011 Nov-Dec;52(6):579-82. doi: 10.1016/j.psym.2011.06.003. No abstract available.

PMID:
22054631
9.

Psychiatric symptoms associated with ephedra use.

Maglione M, Miotto K, Iguchi M, Hilton L, Shekelle P.

Expert Opin Drug Saf. 2005 Sep;4(5):879-84. Review.

PMID:
16111450
10.
11.
12.

Availability of weight-loss supplements: Results of an audit of retail outlets in a southeastern city.

Sharpe PA, Granner ML, Conway JM, Ainsworth BE, Dobre M.

J Am Diet Assoc. 2006 Dec;106(12):2045-51.

PMID:
17126636
13.

Hemodynamic effects of ephedra-free weight-loss supplements in humans.

Haller CA, Benowitz NL, Jacob P 3rd.

Am J Med. 2005 Sep;118(9):998-1003.

PMID:
16164886
14.

Physiological effects following administration of Citrus aurantium for 28 days in rats.

Hansen DK, George NI, White GE, Pellicore LS, Abdel-Rahman A, Fabricant D; Food and Drug Administration.

Toxicol Appl Pharmacol. 2012 Jun 15;261(3):236-47. doi: 10.1016/j.taap.2012.04.006. Epub 2012 Apr 13.

PMID:
22521485
15.

Bitter orange weight loss products may not be safe.

[No authors listed]

Health News. 2004 Dec;10(12):9. No abstract available.

PMID:
15645567
16.

Multi-ingredient, caffeine-containing dietary supplements: history, safety, and efficacy.

Gurley BJ, Steelman SC, Thomas SL.

Clin Ther. 2015 Feb 1;37(2):275-301. doi: 10.1016/j.clinthera.2014.08.012. Epub 2014 Sep 26. Review.

PMID:
25262198
17.

[Case of intractable ventricula fibrillation by a multicomponent dietary supplement containing ephedra and caffeine overdose].

Takeuchi S, Homma M, Inoue J, Kato H, Murata K, Ogasawara T.

Chudoku Kenkyu. 2007 Jul;20(3):269-71. Japanese.

PMID:
17784561
18.

Time to ban ephedra--now.

Guharoy R, Noviasky JA.

Am J Health Syst Pharm. 2003 Aug 1;60(15):1580-2. No abstract available.

PMID:
12951759
19.

Blood pressure and heart rate effects following a single dose of bitter orange.

Bui LT, Nguyen DT, Ambrose PJ.

Ann Pharmacother. 2006 Jan;40(1):53-7. Epub 2005 Nov 29.

PMID:
16317106
20.

Ephedra-containing dietary supplements in the US versus ephedra as a Chinese medicine.

Mehendale SR, Bauer BA, Yuan CS.

Am J Chin Med. 2004;32(1):1-10. Review.

PMID:
15154280

Supplemental Content

Support Center